Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
The European Medicines Agency (EMA) has approved two novel therapies for neurological conditions: Cenrifki for relapsing-remitting multiple sclerosis (RRMS) and Itvisma for spinal muscular atrophy (SMA), marking significant advances in ... Read More
Continuous Coverage
This week, African nations’ gold-driven foreign exchange reserves surged past $530 billion as central banks across the continent…
As of April 24, 2026, Warner Bros. Discovery’s highly anticipated Rush Hour 4 faces significant delays amid unresolved…
When most Americans think of flash points between Washington and Beijing, their minds leap to Taiwan. The island…
Instagram’s modern standalone app, Instants, launches this week on iOS and Android as a direct response to Snapchat’s…
South Korea’s Medical Association (의협) has rejected claims that proposed amendments to the Medical Service Act would allow…
A CPE report released April 24, 2026 finds that high school students who complete dual credit courses are…
Global Affairs
As of late April 2024, Iran’s foreign minister is en route to Pakistan for a second round of…
Markets And Money
On Monday, April 24, 2026, Manfred Paulmann, the eldest son of Horst Paulmann, assumed the presidency of Cencosud…
Digital Culture
On April 24, 2026, the U.S. Department of Justice announced a coordinated takedown of a transnational cybercrime syndicate…
Science And Wellbeing
This week, Opera Orlando announced the expansion of its 2026-27 season to include a third Saturday night performance…
Screen And Sound
On this Tuesday morning of April 24, 2026, as families across America unpack Easter baskets and plan summer…
Fixtures And Form
Rugby fans have flooded into Cardiff for the inaugural match at the newly opened $683 million Principality Stadium…
